NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

1.02
Data as of Jul 28
 +0.0199 / +1.99%
Today’s Change
0.76
Today|||52-Week Range
2.03
-17.07%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$50.8M

Company Description

NovaBay Pharmaceuticals, Inc. is a clinical stage biotechnology company developing an anti-infective platform of compounds called the Aganocide compounds, for the treatment or prevention of infections in hospital and non-hospital environments. The company operates through four business units: Dermatology, Opthalmology, Urology and Wound Care. It was formerly known as NovaCal Pharmaceuticals, Inc. NovaBay Pharmaceuticals was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.

Contact Information

NovaBay Pharmaceuticals, Inc.
5980 Horton Street
Emeryville California 94608
P:(510) 899-8800
Investor Relations:

Employees

Shareholders

Individual stakeholders24.08%
Other institutional2.10%
Mutual fund holders1.98%

Top Executives

Ramin NajafiChairman, President & Chief Executive Officer
Thomas J. PaulsonCFO, CAO, Secretary & Treasurer
Ken KrantzVice President-Medical Affairs
Roy J. WuSenior VP-Business & Corporate Development
Russell A. HoonVice President-Advanced Wound Care Unit

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.